يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"McGlasson, Sarah L."', وقت الاستعلام: 0.47s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: Laboratory of neurogenetics and neuroinflammation (Equipe Inserm U1163), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Immunobiologie des Cellules dendritiques, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre For Clinical Brain Sciences - Neuroimaging Sciences Edinburgh, U.K. (CCBS), University of Edinburgh (Edin.), Medical Research Council (MRC) Human Genetics Unit Edinburgh, University of Edinburgh (Edin.)-MRC Institute of Genetics and Molecular Medicine Edinburgh (IGMM), University of Edinburgh (Edin.)-Medical Research Council-Medical Research Council, Manchester Centre for Genomic Medicine Manchester, UK (MCGM), St Mary's Hospital Manchester-Manchester Academic Health Science Centre (MAHSC), University of Manchester Manchester -University of Manchester Manchester -Manchester University NHS Foundation Trust (MFT)-Faculty of Biology, Medicine and Health Manchester, UK, University of Manchester Manchester, Service d'immuno-hématologie pédiatrique CHU Necker, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Necker - Enfants Malades AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de neurologie pédiatrique CHU Necker, Service de dermatologie CHU Necker, Réponse immunitaire innée dans les maladies infectieuses et auto-immunes – Innate immunity in infectious and autoimmune diseases CIRI, Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon), Université de Lyon-Université de Lyon-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon), Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL), Division of Evolution and Genomic Science Manchester, School of Biological Sciences Manchester -Faculty of Biology, Medicine and Health Manchester, Department of Neurology, Leiden University Medical Center (LUMC), Universiteit Leiden = Leiden University-Universiteit Leiden = Leiden University, Departments of Human Genetics & Neurology, General Paediatrics, Infectious Disease and Internal Medicine Department Robert-Debré, Hôpital Robert Debré, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Department of Microbiology and Immunology, Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven), Pediatric Immunodeficiencies, University Hospitals Leuven Leuven, CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), ImmunoQure AG, Peter Gorer Department of Immunobiology, King‘s College London, The Francis Crick Institute London, Université Paris Descartes - Paris 5 (UPD5), Service de Virologie CHU Cochin, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin AP-HP, Service de Génétique Médicale CHU Necker, Y.J. Crow acknowledges support from the European Research Council (fellowshipGA 309449, fellowship), the European Leukodystrophy Association (ELA 2012-008I1), and a state subsidy managed by the Agence Nationale de la Recherche (ANR, France) under the “Investments for the Future” program bearing the reference ANR-10-IAHU-01. Y.J. Crow and D. Duffy acknowledge support from the ANR (CE17001002).Y.L. Crow and A.M.J.M. van den Maagdenberg acknowledge the EU FP7 project NIM BL(241779). D. Duffy acknowledges funding from a PasteurInnov grant and the EU FP7project PoC-HCV (261365) for development of Simoa assays. S. Wiseman andJ. Wardlaw acknowledge funding from Lupus UK. A. Hayday acknowledges supportfrom the Wellcome Trust (grant 106292/Z/14/Z). F. Rieux-Laucat and Y.J. Crow acknowledgethe ANR (ANR-14-CE14-0026-01 “Lumugene”). D. Hunt is supported bythe Wellcome Trust., ANR-10-IAHU-0001,Imagine,Institut Hospitalo-Universitaire Imagine(2010), ANR-14-CE14-0026,Lumugene,Etude de familles multiplex de lupus pour l'identification de nouveaux gènes à fort impact phénotypique : de la découvertes des gènes à leurs fonctions(2014), European Project: 241779,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,NIMBL(2010), European Project: 261365,EC:FP7:HEALTH,FP7-HEALTH-2010-single-stage,SPHINX(2010)

    المصدر: ISSN: 0022-1007.

    مصطلحات موضوعية: [SDV.IMM]Life Sciences [q-bio]/Immunology

    Relation: info:eu-repo/semantics/altIdentifier/pmid/28420733; info:eu-repo/grantAgreement/EC/FP7/241779/EU/Nuclease Immune Mediated Brain and Lupus-like conditions (NIMBL): natural history, pathophysiology, diagnostic and therapeutic modalities with application to other disorders of autoimmunity/NIMBL; info:eu-repo/grantAgreement/EC/FP7/261365/EU/Spontaneous clearance in Patients acutely infected with HCV - Immune profiling, Novel biomarkers and X-omics approaches/SPHINX; PUBMED: 28420733

  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal